Recent Advances in the Diagnosis and Treatment of Hypereosinophilic Syndromes

DOI PDF 被引用文献2件

抄録

<jats:title>Abstract</jats:title> <jats:p>Hypereosinophilic syndromes (HES) are a heterogeneous group of disorders characterized by marked peripheral blood and tissue eosinophilia resulting in end organ damage. Recent advances in molecular biology and immunology have led to the identification of a number of distinct subtypes of HES with differing epidemiology, pathogenesis, and prognosis. The ability to distinguish between these HES subtypes combined with the availability of new treatment modalities, including tyrosine kinase inhibitors and monoclonal antibodies, that target specific molecules involved in disease pathogenesis have dramatically altered the approach to the diagnosis and treatment of HES.</jats:p>

収録刊行物

  • Hematology

    Hematology 2005 (1), 209-214, 2005-01-01

    American Society of Hematology

被引用文献 (2)*注記

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ